Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis.

Fatima, Hareer; Rangwala, Hussain Sohail; Mustafa, Muhammad Saqlain; Shafique, Muhammad Ashir; Abbas, Syed Raza; Rizwan, Azra; Fadlalla Ahmed, Tagwa Kalool; Arshad, Ainan

Fatima, Hareer; Rangwala, Hussain Sohail; Mustafa, Muhammad Saqlain; Shafique, Muhammad Ashir; Abbas, Syed Raza; Rizwan, Azra; Fadlalla Ahmed, Tagwa Kalool; Arshad, Ainan.

Afiliação

Fatima H; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Rangwala HS; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Mustafa MS; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Shafique MA; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Abbas SR; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Rizwan A; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Fadlalla Ahmed TK; Department of Medicine, Ahfad University for Women, Omdurman, Al-Khartum, Sudan.
Arshad A; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Diabetes Metab Syndr Obes ; 16: 3567-3578, 2023.

Article em En | MEDLINE | ID: mdl-37954886

Palavras-chave

Danuglipron; adverse outcomes; diabetes mellitus; glucagon-like peptide 1 receptor agonists; glycemic parameters

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article